Gastrointestinal Cancers Symposium

The latest news from ASCO GI, including researcher interviews and physician perspective.


Meeting News CoveragePerspective

Short-course chemoradiation regimen effective, less toxic for advanced rectal cancer

January 19, 2016
A short-course 5-day radiation regimen followed by consolidated chemotherapy prior to surgery appeared as effective as and less toxic than the…
Meeting News CoveragePerspective

Lutathera improves outcomes in metastatic midgut neuroendocrine tumors

January 19, 2016
Treatment with 177Lutetium-DOTATE appeared to improve the overall response rate and prolonged PFS compared with octreotide among previously treated…
Meeting News Coverage

Less-intensive regimen maintained efficacy, reduced toxicity in metastatic pancreatic cancer

February 3, 2015
A less-intensive first-line treatment regimen for patients with metastatic pancreatic cancer may decrease toxicity and reduce costs while maintaining…
Meeting News Coverage

Panitumumab plus FOLFOX6 benefited patients with RAS wild-type metastatic colorectal cancer

February 2, 2015
Patients with RAS wild-type metastatic colorectal cancer treated with panitumumab plus modified FOLFOX6 chemotherapy experienced faster and more…
Meeting News Coverage

Lanreotide shows promise in patients with pancreatic neuroendocrine tumors

January 28, 2015
Lanreotide demonstrated antitumor activity with a manageable safety profile in patients with pancreatic neuroendocrine tumors, according to a…
Meeting News CoveragePerspective

Pembrolizumab appears safe, effective in advanced gastric cancer

January 27, 2015
The novel agent pembrolizumab demonstrated promising antitumor activity and manageable toxicity in patients with advanced gastric cancer, according…
Meeting News CoveragePerspective

MM-398 improved outcomes in metastatic pancreatic cancer

January 23, 2015
The addition of the novel agent MM-398 to second-line 5-FU/leucovorin extended survival in patients with metastatic pancreatic cancer, according to…
Meeting News CoveragePerspective

High vitamin D levels linked to improved outcomes in metastatic colorectal cancer

January 13, 2015
High concentrations of vitamin D were associated with improved OS and PFS in patients with metastatic colorectal cancer who received chemotherapy and…
Meeting News CoveragePerspective

Bevacizumab plus FOLFOXIRI extended OS in advanced colorectal cancer

January 13, 2015
Patients with advanced colorectal cancer who underwent first-line treatment with bevacizumab plus FOLFOXIRI chemotherapy demonstrated significantly…
Meeting News CoveragePerspective

Ramucirumab combination benefited patients with advanced colorectal cancer

January 12, 2015
The addition of ramucirumab to standard chemotherapy in a second-line setting extended survival for patients with advanced colorectal cancer…